In Nevro Corp. v. Boston Scientific
Corp., the Federal Circuit vacated the district
court's determination that various claims were invalid as
indefinite under 35 U.S.C. § 112.
At the district court, defendant argued that certain claims were
invalid under § 112 because infringement could only be
determined after using the alleged infringing device or method.
Defendant further argued that the specification failed to explain
how to achieve the claimed therapeutic result with reasonable
certainty and that the claims were susceptible to different
interpretations.
On appeal, the Federal Circuit determined that the district
court failed to apply the correct test for indefiniteness and held
that the appealed claims were not indefinite under § 112.
Applying Nautilus, the Court found that the
specification was sufficient to inform a skilled artisan, with
reasonable certainty, as to the scope of each of the contested
claim terms. Defendant's argument that a potential